<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01819480</url>
  </required_header>
  <id_info>
    <org_study_id>16376</org_study_id>
    <secondary_id>16376</secondary_id>
    <nct_id>NCT01819480</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of TORS for SCCA</brief_title>
  <official_title>A Single Arm Study of Efficacy and Functional Quality of Life in Patients Treated With Transoral Robotic Surgery for Oropharyngeal and Supraglottic Squamous Cell Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mark J Jameson, MD, PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Virginia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn more about the outcomes of treatment of throat and
      voice box cancers using transoral robotic surgery (TORS). TORS is a relatively new option
      involving the use of the da Vinci surgical robot to remove these cancers through the mouth.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Progression-free survival</measure>
    <time_frame>3 years</time_frame>
    <description>Duration of time from date of surgery to date of recurrence or death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disease specific survival</measure>
    <time_frame>3 years</time_frame>
    <description>Duration of time from the date of surgery until death with disease present</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Overall survival</measure>
    <time_frame>3 years</time_frame>
    <description>Measured from the date of surgery until date of death from any cause</description>
  </other_outcome>
  <other_outcome>
    <measure>Functional quality of life</measure>
    <time_frame>3 years</time_frame>
    <description>Subject-reported functional outcome questionnaires will be used to quantify patient-reported speech and swallowing function</description>
  </other_outcome>
  <other_outcome>
    <measure>Incidence of adverse events</measure>
    <time_frame>3 years</time_frame>
    <description>Adverse events occuring following the surgery will be reported and graded using CTCAE v4.0 criteria</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Oropharyngeal Squamous Cell Carcinoma</condition>
  <condition>Supraglottic Squamous Cell Carcinoma</condition>
  <arm_group>
    <arm_group_label>Transoral robotic surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Transoral robotic surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transoral robotic surgery</intervention_name>
    <description>Transoral robotic surgery using the daVinci robot to remove primary tumor</description>
    <arm_group_label>Transoral robotic surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult male or female

          -  Diagnosis of either oropharyngeal or supraglottic squamous cell carcinoma

        Exclusion Criteria:

          -  Metastatic disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark J Jameson, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Virginia School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bette Ghamandi</last_name>
    <phone>434-243-1558</phone>
    <email>bjf8j@hscmail.mcc.virginia.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Virginia Health System</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22908</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Mark J Jameson, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 22, 2013</study_first_submitted>
  <study_first_submitted_qc>March 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 27, 2013</study_first_posted>
  <last_update_submitted>May 4, 2020</last_update_submitted>
  <last_update_submitted_qc>May 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Virginia</investigator_affiliation>
    <investigator_full_name>Mark J Jameson, MD, PhD</investigator_full_name>
    <investigator_title>Assistant Professor, Department of Otolaryngology</investigator_title>
  </responsible_party>
  <keyword>Surgery</keyword>
  <keyword>Robotic</keyword>
  <keyword>Carcinoma</keyword>
  <keyword>squamous cell of head and neck</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Carcinoma, Squamous Cell</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

